LGN:NASDAQLegence Corp. Analysis
Data as of 2026-05-19 - not real-time
$80.38
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Legence Corp. delivered a dramatic revenue surge in Q1, posting double‑digit growth and a record backlog that lifted its full‑year outlook. The earnings beat and upgraded guidance sparked a sharp pre‑market rally, while technicals remain bullish with the price trading well above its short‑ and long‑term moving averages and volume trending higher. Margin pressure persists, as profitability remains marginal and the company carries a high level of leverage.
Valuation appears stretched, with the market price exceeding intrinsic estimates, yet the forward earnings multiple is elevated, reflecting strong growth expectations. The stock offers no dividend and is highly sensitive to market sentiment, given its elevated beta and volatility, but the data‑center and sustainability themes provide a compelling growth narrative for investors willing to tolerate the risk.
Valuation appears stretched, with the market price exceeding intrinsic estimates, yet the forward earnings multiple is elevated, reflecting strong growth expectations. The stock offers no dividend and is highly sensitive to market sentiment, given its elevated beta and volatility, but the data‑center and sustainability themes provide a compelling growth narrative for investors willing to tolerate the risk.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Earnings beat and raised guidance
- Bullish technical positioning with strong volume
- Momentum from data‑center demand
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustained revenue growth trajectory
- Ongoing margin and leverage concerns
- Potential for further upside if guidance remains strong
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic positioning in high‑growth HVAC and data‑center markets
- Long‑term secular demand for sustainable building solutions
- Improving cash flow generation despite current profitability challenges
Key Metrics & Analysis
Financial Health
Revenue Growth105.10%
Profit Margin-0.73%
P/E Ratio46.1
ROE-7.22%
ROA2.40%
Debt/Equity123.90
P/B Ratio13.1
Op. Cash Flow$347.5M
Free Cash Flow$331.3M
Industry P/E29.2
Technical Analysis
TrendBullish
RSI45.9
Support$76.36
Resistance$107.24
MA 20$89.19
MA 50$70.58
MA 200$50.59
MACDBearish
VolumeIncreasing
Fear & Greed Index89.18
Valuation
Fair Value$65.63
Target Price$101.00
Upside/Downside25.65%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.52
Volatility66.20%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.